Evidence map›Paper›PMID 14623968›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A.

Christophe Cans, Brent J Passer, Vyacheslav Shalak, Vanessa Nancy-Portebois, Virginie Crible, Nathalie Amzallag, David Allanic, Rowena Tufino, Manuela Argentini, Dino Moras and 5 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 182 citations in OpenAlex.

  1. Article
  2. Article
  3. Tctp, a unique Ing5-binding partner, inhibits the chromatin binding of Enok inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Christophe CansMolecular Engines Laboratories, 20 Rue Bouvier, 75011 Paris, France.
Brent J Passer
Vyacheslav Shalak
Vanessa Nancy-Portebois
Virginie Crible
Nathalie Amzallag
David Allanic
Rowena Tufino
Manuela Argentini
Dino Moras
Giusy Fiucci
Bruno Goud
Marc Mirande
Robert Amson
Adam Telerman
Centre National pour la Recherche Scientifique et Technique (CNRST) · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, we demonstrated that the expression levels of the translationally controlled tumor protein (TCTP) were strongly down-regulated at the mRNA and protein levels during tumor reversion/suppression and by the activation of p53 and Siah-1. To better characterize the function of TCTP, a yeast two-hybrid hunt was performed. Subsequent analysis identified the translation elongation factor, eEF1A, and its guanine nucleotide exchange factor, eEF1Bbeta, as TCTP-interacting partners. In vitro and in vivo studies confirmed that TCTP bound specifically eEF1Bbeta and eEF1A. Additionally, MS analysis also identified eEF1A as a TCTP interactor. Because eEF1A is a GTPase, we investigated the role of TCTP on the nucleotide exchange reaction of eEF1A. Our results show that TCTP preferentially stabilized the GDP form of eEF1A, and, furthermore, impaired the GDP exchange reaction promoted by eEF1Bbeta. These data suggest that TCTP has guanine nucleotide dissociation inhibitor activity, and, moreover, implicate TCTP in the elongation step of protein synthesis.

Indexed as

Biomarkers, TumorDrug StabilityGuanine Nucleotide Dissociation InhibitorsGuanine NucleotidesGuanosine DiphosphateHumansIn Vitro TechniquesKineticsPeptide Elongation Factor 1Protein BiosynthesisRecombinant Fusion ProteinsTumor Protein, Translationally-Controlled 1Two-Hybrid System TechniquesBiomarkers, TumorGuanine Nucleotide Dissociation InhibitorsGuanine NucleotidesGuanosine DiphosphatePeptide Elongation Factor 1Recombinant Fusion ProteinsTPT1 protein, humanTumor Protein, Translationally-Controlled 1

Identifiers

PMID14623968
PMCPMC283517
OpenAlexW2134837839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.